Bluecrest Screening secures £17m investment

Mid-market private equity firm Vespa Capital has invested £17m in Bluecrest Health Screening, which provides a range of direct to consumer health checks from dedicated…

You must be a HM Subscriber to view this content.

Subscribe Now »